Clinical Trial Update: Neuromuscular Blockade in Patients With Severe Renal Impairment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neuromuscular blockade in patients with severe renal impairment has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade
• Renal Impairment

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Neuromuscular Blockade, Renal Impairment | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03